But that's just it. For instance, the FDA just the other week denied approval to a hopeful competitor to DaVinci, called SurgiBot. This is preventing competitio

But that's just it. For instance, the FDA just the other week denied approval to a hopeful competitor to DaVinci, called SurgiBot. This is preventing competition from driving costs down. Hopefully the big new entrants, Johnson & Johnson in partnership with Google, will have enough clout to shake things up. It is not only difficult to bring new products to market, but also difficult to improve existing products. The 510k application process is claimed to be getting less onerous, but yet it still takes over a year to get a decision after submission. It's just hard to get anything out there in our highly regulated, litigious, and fearful society. The rapid iteration that we like to see in tech can't do its magic in this environment.